We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.56%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$100B
AUM Growth
-$9.45B
(-8.6%)
Cap. Flow
-$5.83B
Cap. Flow
% of AUM
-5.81%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
3,811
New
911
Increased
1,180
Reduced
974
Closed
681
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$3.97B |
| 2 |
Chevron
CVX
|
+$527M |
| 3 |
Apple
AAPL
|
+$449M |
| 4 |
Morgan Stanley
MS
|
+$426M |
| 5 |
Airbnb
ABNB
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.21B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.87B |
| 3 |
Walmart Inc
WMT
|
+$831M |
| 4 |
Amazon
AMZN
|
+$692M |
| 5 |
Eli Lilly
LLY
|
+$641M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Consumer Discretionary | 11.57% |
| 3 | Healthcare | 9.79% |
| 4 | Financials | 6.87% |
| 5 | Industrials | 5.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Lineage Cell Therapeutics
LCTX
$257M
| $4.84M | ﹤0.01% |
3,065,033
+1,702,972
| +125% | +$2.87M |
|
1302
Palisade Bio
PALI
$339M
| $4.82M | ﹤0.01% |
+2,754,403
| New | +$5.01M |
|
1303
8x8 Inc
EGHT
$247M
| $4.81M | ﹤0.01% |
2,898,685
+2,265,476
| +358% | +$4.64M |
|
1304
Edgewell Personal Care
EPC
$1.27B
| $4.81M | ﹤0.01% |
225,325
+187,829
| +501% | +$3.78M |
|
1305
Emergent Biosolutions
EBS
$375M
| $4.8M | ﹤0.01% |
577,734
-165,721
| -22% | -$1.72M |
|
|
LTC
1306
LTC Properties
LTC
$2.16B
| $4.78M | ﹤0.01% |
128,538
-111,582
| -46% | -$4.2M |
|
1307
iShares US Medical Devices ETF
IHI
$3.02B
| $4.77M | ﹤0.01% |
+89,493
| New | +$5.26M |
|
1308
Annexon
ANNX
$855M
| $4.77M | ﹤0.01% |
861,475
+340,477
| +65% | +$1.92M |
|
|
MIAX
1309
Miami International Holdings
MIAX
$4.14B
| $4.77M | ﹤0.01% |
+122,619
| New | +$5.05M |
|
1310
Xerox
XRX
$337M
| $4.77M | ﹤0.01% |
3,694,481
+610,864
| +20% | +$1.21M |
|
1311
Marriott Vacations Worldwide
VAC
$3.24B
| $4.76M | ﹤0.01% |
73,133
+69,655
| +2,003% | +$4.32M |
|
1312
Loar Holdings
LOAR
$6.64B
| $4.75M | ﹤0.01% |
82,991
+2,413
| +3% | +$163K |
|
1313
TRX Gold Corp
TRX
$255M
| $4.74M | ﹤0.01% |
3,159,119
+1,357,411
| +75% | +$2M |
|
1314
Franklin FTSE India ETF
FLIN
$2.69B
| $4.74M | ﹤0.01% |
+142,567
| New | +$5.21M |
|
1315
Medpace
MEDP
$16.8B
| $4.73M | ﹤0.01% |
9,853
-35,098
| -78% | -$18M |
|
|
NFGC
1316
New Found Gold
NFGC
$534M
| $4.73M | ﹤0.01% |
2,437,006
+1,904,167
| +357% | +$5.11M |
|
1317
Varonis Systems
VRNS
$5.25B
| $4.72M | ﹤0.01% |
219,952
+65,588
| +42% | +$1.78M |
|
1318
Sotera Health
SHC
$4.95B
| $4.69M | ﹤0.01% |
327,298
+87,128
| +36% | +$1.45M |
|
|
VSXY
1319
Victoria's Secret
VSXY
$6.64B
| $4.69M | ﹤0.01% |
101,165
-1,691,562
| -94% | -$94.4M |
|
1320
ODDITY Tech
ODD
$708M
| $4.66M | ﹤0.01% |
348,057
+13,519
| +4% | +$339K |
|
1321
Red Violet
RDVT
$859M
| $4.66M | ﹤0.01% |
134,589
+46,683
| +53% | +$2.05M |
|
1322
Four Corners Property Trust
FCPT
$2.86B
| $4.65M | ﹤0.01% |
196,408
-766,796
| -80% | -$19M |
|
|
TIGR
1323
UP Fintech Holding
TIGR
$845M
| $4.64M | ﹤0.01% |
735,743
-1,283,454
| -64% | -$10.5M |
|
1324
Omnicell
OMCL
$1.86B
| $4.62M | ﹤0.01% |
138,390
+110,265
| +392% | +$4.62M |
|
|
BRCB
1325
Black Rock Coffee Bar Inc
BRCB
$170M
| $4.61M | ﹤0.01% |
356,785
+194,538
| +120% | +$3.15M |
|
Similar funds
Marshall Wace's Q1 2026 Portfolio in Review
As of Q1 2026, Marshall Wace held 3,811 positions worth $100B, down 8.6% from $110B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Marshall Wace withdrew a net $5.83B in Q1 2026, closing 681 positions and reducing 974 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $2.87B position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Marshall Wace opened a new position in State Street SPDR Portfolio S&P 500 ETF worth $3.8B.
- Marshall Wace's largest Q1 2026 buy was State Street SPDR Portfolio S&P 500 ETF: 49,650,246 shares worth $3.8B.
- Marshall Wace added most to Chevron in Q1 2026, an estimated $527M increase.
- Marshall Wace's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.21B.
- Marshall Wace fully exited Vanguard S&P 500 ETF in Q1 2026, selling an estimated $2.87B.
- Marshall Wace's ten largest holdings make up 32% of its $100B portfolio in Q1 2026.
- Marshall Wace opened 911 new positions and closed 681 in Q1 2026.
- Marshall Wace's portfolio value fell 8.6% quarter-over-quarter to $100B.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.